34 participants
Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-04
- Start Date:
- 2023-11-13
- Completion:
- 2027-03-31
Conditions
- Head and Neck Squamous Cell Carcinoma
Interventions
- DRUG
No Results Yet